Bay Street News, 2024

Gained global registrational clarity for naporafenib and achieved key clinical milestones for naporafenib, ERAS-007, and ERAS-801 Multiple data readouts expected […]

DALLAS, March 27, 2024 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company […]

SAN MATEO, Calif., March 27, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing […]

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF (the “Fund”) announces results of […]

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — (TSX: XLVE) Mulvihill U.S. Health Care Enhanced Yield ETF (the “Fund”) announces results […]

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — Mulvihill Premium Yield Fund (the “Fund”) (TSX: MPY) announces results of operations for […]

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported […]

BOSTON, March 27, 2024 (GLOBE NEWSWIRE) — Clip Money, Inc. (“Clip”) (TSXV:CLIP) (OTCQB:CLPMF), a leading provider of end-to-end cash management […]

PLANO, Texas, March 27, 2024 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”) (NASDAQ: SNAX), an emerging healthy […]

THE WOODLANDS, Texas, March 27, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH), one of the nation’s largest and most […]